SOVF - ETF AI Analysis
Top Page
Sovereign's Capital Flourish Fund (SOVF)
Rating:69Neutral
Price Target:―
Positive Factors
Recent Performance Momentum
The fund has shown positive returns over the past month, three months, and year-to-date, indicating recent upward momentum.
Sector Diversification Within the U.S.
Holdings are spread across technology, financials, industrials, health care, and several other sectors, which helps reduce the impact of weakness in any single industry.
Several Strong Top Holdings
Some of the largest positions, such as Molina Healthcare, Primerica, and Insperity, have delivered strong gains so far this year, supporting the fund’s overall results.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high, which means more of the returns are eaten up by fees compared with many low-cost ETFs.
Heavy U.S.-Only Focus
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. economy.
Mixed Performance Among Top Holdings
Several key positions, including Paycom, Alkami Technology, Grand Canyon Education, and Fiserv, have shown weak or negative performance this year, which could weigh on future returns if the trend continues.
SOVF vs. SPDR S&P 500 ETF (SPY)
AUM90.26M
RegionNorth America
Expense Ratio0.75%
Beta0.88
IssuerSovereign's
Inception DateOct 03, 2023
Dividend Yield0.7%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,775
30 Day Avg. Volume10,638
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.96Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering80
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SOVF Summary
SOVF, the Sovereign's Capital Flourish Fund, is a U.S. stock ETF that aims to cover the total market, from smaller up‑and‑coming businesses to larger, more established companies. It doesn’t track a single index, but instead mixes growth and value stocks across many sectors, with a big focus on technology and financial firms. Well-known names in the fund include Fiserv and Molina Healthcare. An investor might choose SOVF for broad diversification in one fund and the potential for long-term growth. However, its value can rise and fall with the overall stock market, especially tech and financial stocks.
How much will it cost me?The Sovereign's Capital Flourish Fund (SOVF) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, aiming to balance growth and value strategies across a diverse range of market segments.
What would affect this ETF?The Sovereign's Capital Flourish Fund (SOVF) could benefit from growth in the technology and healthcare sectors, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to drive market performance. However, potential risks include economic slowdowns or rising interest rates, which could negatively impact financial and industrial stocks, as well as broader market volatility affecting its diversified portfolio. The fund's focus on U.S.-based companies also makes it sensitive to domestic regulatory changes and economic conditions.
SOVF Top 10 Holdings
This U.S.-focused fund leans heavily into financial and tech-related names, with a few standout players steering returns. On the bright side, Primerica and Insperity are both rising and giving the portfolio a solid lift, while Euronet and Paycom add to the momentum despite some choppy trading signals. Molina Healthcare has been more mixed, occasionally losing steam, and Grand Canyon Education has been lagging, acting as a bit of a brake. Overall, the ETF’s story is one of concentrated bets in U.S. financial and technology ecosystems, with a supporting cast in health care and utilities.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Paycom | 4.68% | $4.23M | $9.69B | -3.43% | 76 Outperform | |
| Molina Healthcare | 4.15% | $3.74M | $10.25B | 29.26% | 71 Outperform | |
| Qualcomm | 3.71% | $3.35M | $176.29B | 9.60% | 80 Outperform | |
| Alkami Technology | 3.70% | $3.34M | $2.11B | -5.03% | 61 Neutral | |
| Repay Holdings | 3.53% | $3.18M | $347.94M | -28.54% | 51 Neutral | |
| Grand Canyon Education | 3.36% | $3.03M | $3.98B | -25.17% | 74 Outperform | |
| Euronet Worldwide | 3.09% | $2.78M | $2.70B | -23.50% | 66 Neutral | |
| SPS Commerce | 3.07% | $2.77M | $2.64B | -28.58% | 77 Outperform | |
| Vistra Corp | 3.04% | $2.74M | $47.40B | -28.59% | 65 Neutral | |
| Option Care Health | 3.02% | $2.72M | $3.56B | -12.03% | 73 Outperform |
SOVF Technical Analysis
Positive
―
Price Trends
29.93
Positive
29.02
Positive
28.89
Positive
Market Momentum
0.60
Negative
69.82
Neutral
90.02
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SOVF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.01, equal to the 50-day MA of 29.93, and equal to the 200-day MA of 28.89, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 69.82 is Neutral, neither overbought nor oversold. The STOCH value of 90.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SOVF.
SOVF Peer Comparison
Comparison Results
Performance Comparison
SOVF
Sovereign's Capital Flourish Fund
32.19
2.01
6.66%
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
YALL
God Bless America ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents